Search Results - "Altwein, J.E."

Primary and secondary prevention of prostate cancer by Altwein, J.E.

“…Due to the very high prevalence of prostate cancer (>20% among men aged 50–60), prevention is essential. In contrast to chemoprevention (e.g. with…”
Get full text

The Probiotic Approach: An Alternative Treatment Option in Urology by Hoesl, C.E., Altwein, J.E.

“…The prophylactic and therapeutic use of probiotic microorganisms is a wide and still controversial field. The review paper is aimed to summarize recent…”
Get full text

Erectile Dysfunction (ED) is Prevalent, Bothersome and Underdiagnosed in Patients Consulting Urologists for Benign Prostatic Syndrome (BPS) by Hoesl, C.E., Woll, E.M., Burkart, M., Altwein, J.E.

“…The aim of the present study was to determine the prevalence of erectile dysfunction (ED) in patients visiting office-based urologists in Germany because of…”
Get full text

Unusually large numbers needed to treat for radical prostatectomy in prostate cancer patients with PSA velocity ≤2 ng/ml/year by Scheerer, J, Kahabka, P, Altwein, J E, Weißbach, L

“…The numbers needed to treat (NNT) and the corresponding confidence intervals for patients with prostate cancer and defined annual PSA increases (PSA velocity,…”
Get more information

Reversible, Non-Barrier Male Contraception: Status and Prospects by Hoesl, C.E., Saad, F., Pöppel, M., Altwein, J.E.

“…Male, non-barrier, contraceptive options are limited to vasectomy and inadequate methods such as withdrawal and periodic abstinence. Herein we give an overview…”
Get full text

Prostate and sexuality: An overview by Burger, B, Weidner, W, Altwein, J E

“…Diseases of the prostate, prostatitis, prostatodynia, benign prostatic hyperplasia (BPH), and carcinoma of the prostate interfere with sexual function. Since…”
Get more information

Biphosphonates in advanced prostate and renal cell cancer--current status and potential applications by Hoesl, C E, Altwein, J E

“…This review summarizes recent findings on the therapeutic benefits of biphosphonates in patients with advanced prostate or renal cell carcinoma (RCC). The role…”
Get more information

The role of apomorphine SL in the treatment of male erectile dysfunction by Heaton, J.P.W., Altwein, J.E.

Get full text

Differential Diagnosis and Evaluation of the Clinical Course of Transurethrally Resected T1G3 Urothelial Carcinoma of the Bladder by DNA Image Cytometry by BIESTERFELD, S, BORCHERS, H, JELLOUSCHEK, H, BONO, A. V, ALTWEIN, J. E, ALGABA, F, JAKSE, G

“…The value of DNA image cytometry in the differential diagnosis of 106 T1G3 urothelial carcinomas of the bladder and the long-term prognosis (recurrence-free…”
Get full text

Oral treatment of erectile dysfunction with apomorphine SL by Altwein, J E, Keuler, F U

“…Apomorphine SL (Ixense, Uprima) is a new oral medication shown to be effective in the treatment of erectile dysfunction. This compound is a dopaminergic…”
Get more information

Treatment options after failure of local curative treatments in prostate cancer: a controversial issue by Schulman, C.C., Altwein, J.E., Zlotta, A.R.

Get full text

Obstructive benign prostatic hyperplasia: therapeutical aspects by Altwein, J E

“…Once benign prostatic obstruction (BPO) is diagnosed, the urologist is confronted with an array of therapeutic modalities, from which he has to choose. The…”
Get more information

Simultaneous radical prostatectomy and partial rectum resection without colostomy by Baur, H, Frimberger, M, Altwein, J E

“…The simultaneous occurrence of carcinoma of the rectum and prostate is observed in 6%. Ablative surgery in two sessions is technically more difficult than in a…”
Get more information

Enhancing the efficacy of radical prostatectomy in locally advanced prostate cancer by Altwein, J E

“…Locally advanced prostate cancer patients comprise those with iatrogenic capsular injury, extracapsular extension resulting in positive surgical margins…”
Get more information

Prognostic factors for carcinoma of the prostate by Altwein, J E, Luboldt, H J

“…Prognostic factors for prostatic carcinoma should be significant, independent and clinically important. They should be of practical use, and their…”
Get more information

Primärprävention des Blasenkarzinoms: Was gibt es Neues? by Altwein, J.E.

Get full text

Adjuvant hormonal therapy following radical prostatectomy by Beyer, A, Leitenberger, A, Altwein, J E

“…The benefit of adjuvant treatment after radical prostatectomy in patients with extracapsular or node-positive disease is still being evaluated. In a…”
Get more information

Is there a change in the treatment of benign prostatic hyperplasia? by Altwein, J E, Almer, F

Get more information

Efficacy and discriminative ability of prostate-specific antigen as a tumor marker by Leitenberger, A, Altwein, J E

“…A study was performed on 175 men to compare the level of prostate-specific antigen (PSA) in patients with benign prostatic hyperplasia (n = 83) and prostatic…”
Get more information

ESWL of stones in the mid-ureter by Ruckdeschel, M, Bauer, E, Schneider, W, Altwein, J E

“…Two hundred and twenty patients with a ureteric calculus were treated by in situ ESWL; in 60 of these the stone was located in the mid-ureter. Treatment was…”
Get more information